Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

Clinics in Liver Disease

Volumn 16, Issue 1, 2012, Pages 133-146

  Riggio, Oliviero ^a   Nardelli, Silvia ^a   Moscucci, Federica ^a   Pasquale, Chiara ^a   Ridola, Lorenzo ^a   Merli, Manuela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hepatic encephalopathy; Portal hypertension; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ASCITES; BEHAVIOR CHANGE; CHRONIC DISEASE; COMA; CONSCIOUSNESS DISORDER; DECOMPRESSION; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HEPATITIS; HIGH RISK PATIENT; HUMAN; INCIDENCE; LIVER FAILURE; LIVER VEIN; MENTAL HEALTH; NEUROMUSCULAR FUNCTION; PORTAL HYPERTENSION; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PREDICTION; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SPLANCHNIC BLOOD FLOW; SURVIVAL; SYSTEMIC CIRCULATION; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT INDICATION;

HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE;

EID: 84856623428     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2011.12.008     Document Type: Review

References (65)

1. Boyer T.D., Haskal Z.J. AASLD practice guidelines: the role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Hepatology 2010, 51:1-16.
2. de Franchis R., Baveno V Faculty Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. JHepatol 2010, 53:762-768.
3. DeGasperi A., Corti A., Corso R., et al. Transjugular intrahepatic portosystemic shunt (TIPS): the anesthesiological point of view after 150 procedures managed under total intravenous anesthesia. JClin Monit Comput 2009, 23:341-346.
4. Shiffman M.L., Jeffers L., Hoofnagle J.H., et al. Role of transjugular intrahepatic portosystemic shunt treatment of portal hypertension and its complication: conference sponsored by the National Digestive Diseases Advisory Board. Hepatology 1995, 22:1591-1597.
5. Rösch J., Keller F.S. Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives. World J Surg 2001, 25:337-346.
6. Rössle M., Richter G.M., Noldge G., et al. New non-operative treatment for variceal haemorrhage. Lancet 1989, 2:153.
7. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
8. Watanabe A. Portal-systemic encephalopathy in non-cirrhotic patients: classification of clinical types, diagnosis and treatment. JGastroenterol Hepatol 2000, 15:969-979.
9. Crespin J., Nemcek A., Rehkemper G., et al. Intrahepatic portal-hepatic venous anastomosis: a portal-systemic shunt with neurological repercussions. Am J Gastroenterol 2000, 95:1568-1571.
10. Minguez B., Garcia Pagan J.C., Bosch J., et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006, 43:707-714.
11. Balata S., Olde Damink S., Ferguson K., et al. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 2003, 37:931-939.
12. Klempnaue J., Schrem H. Review: surgical shunts and encephalopathy. Metab Brain Dis 2001, 16:21-28.
13. Hanna S.S., Smith R.B., Henderson J.M., et al. Reversal of hepatic encephalopathy after occlusion of total portosystemic shunts. Am J Surg 1981, 142:285-289.
14. Sanjal A.J., Freedman A., Shiffman M.L., et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994, 20:46-55.
15. Somberg K.A., Riegler J.L., LaBerge J.M., et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors. Am J Gastroenterol 1995, 90:549-555.
16. Riggio O., Merli M., Pedretti R., et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996, 41:578-584.
17. Sarfeh I.J., Rypins E.B. Partial versus total portacaval shunt in alcoholic cirrhosis: results of a prospective, randomized clinical trial. Ann Surg 1994, 219:353-361.
18. Riggio O., Nicolao F., Angeloni S., et al. Intractable hepatic encephalopathy after TIPS with polytetrafluoroethylene-covered stent-graft. Scand J Gastroenterol 2002, 37:249-252.
19. Nolte W., Wiltfang J., Schindler C., et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 1998, 28:1215-1225.
20. Bureau C., Garcia-Pagan J.C., Otal P., et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004, 126:469-475.
21. Alvarez W., Piera C., Bandi J.C., et al. Quantification of the extent of portal systemic shunting before and after TIPS: relationship with portal systemic encephalopathy. Hepatology 1995, 22:296A.
22. Cabrera J., Maynar M., Granados R., et al. TIPS vs. sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996, 110:832-839.
23. Zuckerman D.A., Darcy M.D., Bocchini T.P., et al. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis and incidence of potential risk factors. AJR Am J Roentgenol 1997, 169:1727-1731.
24. Rossle M., Haag K., Ochs A., et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. NEngl J Med 1994, 330:165-171.
25. Jalan R., Elton R.A., Redhead D.N., et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal hemorrhage. JHepatol 1995, 23:123-128.
26. Rossle M., Deibert P., Haag K., et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997, 349:1043-1049.
27. Jalan R., Forrest E.H., Stanley A.J., et al. Arandomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997, 26:1115-1122.
28. Sanyal A.J., Freedman A.M., Luketic V.A., et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997, 126:849-857.
29. Cello J.P., Ring E.J., Olcott E.W., et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997, 126:858-865.
30. Sauer P., Theilman L., Stremmer W., et al. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997, 113:1623-1631.
31. Merli M., Salerno F., Riggio O., et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology 1998, 27:40-45.
32. Lebrec D., Giuily N., Hadengue A., et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. JHepatol 1996, 25:135-144.
33. Rössle M., Ochs A., Gülberg V., et al. Acomparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. NEngl J Med 2000, 342:1701-1717.
34. Ginès P., Uriz J., Calahorra B., et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002, 123:1839-1847.
35. Sanyal A.J., Genning C., Reddy K.R., et al. The North American study for the treatment of refractory ascites. Gastroenterology 2003, 124:634-641.
36. Salerno F., Merli M., Riggio O., et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004, 40:629-635.
37. Narahara Y., Kanazawa H., Fukuda T., et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. JGastroenterol 2011, 46:78-85.
38. Burroughs A.K., Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol 2002, 37:249-252.
39. Yang Z., Han G., Wu Q., et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. JGastroenterol Hepatol 2010, 25:1718-1725.
40. Masson S., Mardini H.A., Rose J.D., et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM 2008, 101:493-501.
41. Riggio O., Angeloni S., Salvatori F.M., et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 2008, 103:2738-2746.
42. Riggio O., Ridola L., Lucidi C., et al. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?. Dig Liver Dis 2010, 42:462-467.
43. Casado M., Bosch J., Garcia-Pagan J.C., et al. Clinical events after TIPS: correlation with hemodynamic findings. Gastroenterology 1998, 114:1296-1303.
44. Bai M., Qi X., Yang Z., et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. JGastroenterol Hepatol 2011, 26:943-951.
45. Guevara M., Baccaro M.E., Rios J., et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010, 30:1137-1142.
46. Riggio O., Masini A., Efrati C., et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. JHepatol 2005, 42:674-679.
47. Kochar N., Tripathi D., Ireland H., et al. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut 2006, 55:617-623.
48. Romero-Gomez M., Jover M., Diaz-Gomez D., et al. Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis. World J Gastroenterol 2006, 12:2406-2411.
49. Riggio O., Ridola L., Angeloni S., et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. JHepatol 2010, 53:267-272.
50. Colombato L.A., Spahr L., Martinet J.P., et al. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut 1996, 39:600-604.
51. Merli M., Valeriano V., Funaro S., et al. Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS). Am J Gastroenterol 2002, 97:142-148.
52. Riggio O., Ridola L., Pasquale C. Hepatic encephalopathy therapy: an overview. World J Gastrointest Pharmacol Ther 2010, 6:54-63.
53. Cookson D.T., Zaman Z., Gordon-Smith J., et al. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series. Cardiovasc Intervent Radiol 2011, 34:92-99.
54. Fanelli F., Salvatori F.M., Rabuffi P., et al. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. AJR Am J Roentgenol 2009, 193:1696-1702.
55. Chung H.H., Razavi M.K., Sze D.Y., et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?. JGastroenterol Hepatol 2008, 23:95-101.
56. Maleux G., Heye S., Verslype C., et al. Management of transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study. JVasc Interv Radiol 2007, 18:986-992.
57. Kerlan R.K., LaBerge J.M., Baker E.L., et al. Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts. JVasc Interv Radiol 1995, 6:917-921.
58. Salerno F., Cammà C., Enea M., et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007, 133:825-834.
59. Garcia Pagan G.C., Caca K., Bureau C., et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. NEngl J Med 2010, 362:2370-2379.
60. Lo G.H., Liang H.L., Chen W.C., et al. Aprospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007, 39:679-685.
61. Sauer P., Hansmann J., Richter G.M., et al. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 2002, 34:690-697.
62. Gülberg V., Schepke M., Geigenberger G., et al. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol 2002, 37:338-343.
63. Escorsell A., Banares R., Garcia Pagan J.C., et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002, 35:385-392.
64. Pomier-Layrargues G., Villeneuve P., Deschenes M., et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001, 48:390-396.
65. Garcia Villareal L., Martinez-Lagares F., Sierra A., et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 1999, 29:27-32.